Imagine Mithra, a substantial holder seeing Mayne failing so badly. I honestly think pressure must be mounting internally over the management failures of this company.
- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
1.38%
!
$5.14

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.14 |
Change
0.070(1.38%) |
Mkt cap ! $418.4M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $258.4K | 50.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 706 | $5.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.14 | 1375 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 686 | 5.120 |
6 | 3775 | 5.110 |
8 | 2315 | 5.100 |
2 | 575 | 5.090 |
2 | 599 | 5.080 |
Price($) | Vol. | No. |
---|---|---|
5.130 | 1 | 1 |
5.140 | 1135 | 4 |
5.150 | 10981 | 3 |
5.160 | 547 | 3 |
5.170 | 711 | 2 |
Last trade - 13.15pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online